ASN Kidney360
@ASNKidney360
Followers
12K
Following
734
Media
2K
Statuses
3K
This account will no longer actively post. Follow @asnpublications for the latest from ASN publications, including JASN, CJASN, Kidney360, and Kidney News.
Washington, DC
Joined December 2018
We are no longer posting on this account. Follow us on @asnpublications for the latest from ASN publications, including JASN, CJASN, Kidney360, and Kidney News.
0
0
3
Beginning February 3, we will no longer actively post on this account. Follow us on @asnpublications (currently CJASN) for the latest from ASN publications, including JASN, CJASN, Kidney360, and Kidney News.
0
0
0
This article provides a comprehensive review of MTX metabolism, mechanisms and prevention of MTX-AKI, and its management.
1
19
43
Beginning February 3, we will no longer actively post on this account. Follow us on @asnpublications (currently CJASN) for the latest from ASN publications, including JASN, CJASN, Kidney360, and Kidney News.
0
0
0
RT @ShiuLab: Honored to contribute an editorial to @ASNKidney360 on the insightful study by Nath et al. in the latest issue ! 👏 @NEH_CVRTI….
0
5
0
The American Society of Nephrology seeks applications for Editor-in-Chief of Kidney360, one of three journals in the ASN portfolio which also includes JASN and CJASN. Learn more about the position and the application process here:
0
0
1
Beginning February 3, we will no longer actively post on this account. Follow us on @asnpublications (currently CJASN) for the latest from ASN publications, including JASN, CJASN, Kidney360, and Kidney News.
0
0
0
This study found that intraperitoneal phloretin therapy followed a distinct dose-response relationship, showing high potency in improving ultrafiltration and reducing glucose absorption in experimental PD. @CarlMikaelOberg
0
3
10
Life Years from Transplant (LYFT) is a measure of the predicted difference between the expected lifespan with and without a kidney transplant. This study found that less homogenous metrics with meaningful disaggregation are needed to inform institutional evaluation and policy
1
2
6
Beginning February 3, we will no longer actively post on this account. Follow us on @asnpublications (currently CJASN) for the latest from ASN publications, including JASN, CJASN, Kidney360, and Kidney News.
0
0
1
RT @LippincottMed: Your Basic Research deserves the spotlight! Did you know that JASN® and Kidney360® are eager to publish your basic resea….
0
3
0
RT @ASNKidney: Apply now for Editor-in-Chief of @ASNKidney360! Lead the direction of cutting-edge kidney research and shape the future of….
0
2
0
Editors’ Choice 2024: Kidney Outcomes with Sodium-Glucose Co-transporter 2 Inhibitor Initiation after Acute Kidney Injury among Veterans with Diabetic Kidney Disease. This study found that SGLT2i use was associated with a lower risk for CKD progression and for recurrent AKI among
0
9
15
Editors’ Choice 2024: Is Gastric Acid Suppression Therapy Linked with Peritoneal Dialysis–Associated Peritonitis?. Peritonitis is a major peritoneal dialysis–related complication. This study found that the association between GAS use and peritonitis risk was weaker than for
0
7
12
Editors’ Choice 2024: Continuous Glucose Monitoring and Diabetes-Related Hospitalizations in Patients with Type 2 Diabetes and Kidney Disease. There is a heightened risk of glycemic variability in patients with diabetes and CKD. This study found that initiation of CGM was
0
0
4
Editors’ Choice 2024: Tumor Necrosis Factor from the Proximal Nephron Exacerbates Aristolochic Acid Nephropathy. Aristolochic acid nephropathy (AAN) presents with tubular epithelial cell (TEC) damage and tubulointerstitial inflammation. This study found that TNF from the proximal
0
1
5
Editors’ Choice 2024: Senescence in Heme Protein–Induced Acute Kidney Injury. This study found that the pathogenesis of HP-AKI involves senescence and the induction of p16Ink4a, the latter driven, in part, by hemoglobin, myoglobin, and heme. @GarovicVesna
0
1
3
Kidney360’s mission is to publish scientifically rigorous research that includes content from all disciplines of kidney science. The editors have selected five Editors’ Choice Articles to highlight the outstanding quality and broad spectrum of published content from 2024. Find
0
1
2
The American Society of Nephrology seeks applications for Editor-in-Chief of Kidney360, one of three journals in the ASN portfolio which also includes JASN and CJASN. Learn more about the position and the application process here:
0
1
2